Oncimmune Holdings plc (LON:ONC) Insider Adam Hill Buys 48,370 Shares

Posted by on Jun 6th, 2023

Oncimmune Holdings plc (LON:ONC – Get Rating) insider Adam Hill acquired 48,370 shares of the stock in a transaction on Monday, June 5th. The shares were purchased at an average price of GBX 21 ($0.26) per share, for a total transaction of £10,157.70 ($12,627.67).

Oncimmune Trading Up 1.0 %

LON ONC opened at GBX 20.15 ($0.25) on Tuesday. The firm’s 50 day moving average price is GBX 37.73 and its two-hundred day moving average price is GBX 47.06. The company has a debt-to-equity ratio of 677.62, a quick ratio of 0.63 and a current ratio of 0.46. Oncimmune Holdings plc has a twelve month low of GBX 18 ($0.22) and a twelve month high of GBX 106.09 ($1.32). The stock has a market cap of £14.94 million, a price-to-earnings ratio of -143.93 and a beta of 0.50.

About Oncimmune

(Get Rating)

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.

Featured Articles

Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.